Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 2
2019 7
2020 7
2021 14
2022 24
2023 33
2024 22
2025 9
2026 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomes.
De Brek N, Peyrottes A, Diamand R, Ploussard G, Oderda M, Matos Da Silva Maia R, Sasia A, Fourcade A, Siebert C, Benamran D, Benard V, Rysankova K, Méjean A, Timsit MO, Dariane C. De Brek N, et al. Among authors: diamand r. Urol Oncol. 2026 May 29;44(8):61-69. doi: 10.1016/j.urolonc.2026.05.009. Online ahead of print. Urol Oncol. 2026. PMID: 42214858 Free article.
Reply to A. Light, H. Ahmed H, T. Shah's Letter to the Editor re: M. Baboudjian, A. Uleri, J. Anract, et al. Targeted, Perilesional, and Distant Biopsies in Prostate Cancer Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.02.006.
Uleri A, Diamand R, Ploussard G, Baboudjian M. Uleri A, et al. Among authors: diamand r. Eur Urol Oncol. 2026 Apr 25:S2588-9311(26)00109-4. doi: 10.1016/j.euo.2026.04.004. Online ahead of print. Eur Urol Oncol. 2026. PMID: 42036285 No abstract available.
Targeted, Perilesional, and Distant Biopsies in Prostate Cancer.
Baboudjian M, Uleri A, Anract J, Brabant L, Assenmacher G, Baudewyns A, Peyrottes A, Sanguedolce F, Fiard G, Renard-Penna R, Hubner N, Messas A, Windisch O, Long-Depaquit T, Toledano H, Sordelli F, Colinet V, Bastide C, Peltier A, Ploussard G, Diamand R. Baboudjian M, et al. Among authors: diamand r. Eur Urol Oncol. 2026 Feb 23:S2588-9311(26)00043-X. doi: 10.1016/j.euo.2026.02.006. Online ahead of print. Eur Urol Oncol. 2026. PMID: 41735130
Radiomics and Image-based Artificial Intelligence for Predicting Recurrence and Survival After Surgery in Localized Renal Cell Carcinoma: An APPRAISE-AI Systematic Review and Meta-analysis.
Mjaess G, Diamand R, Dikete N, Kwong JCC, Pezzullo M, Margue G, Pasoglou V, Michoux N, Campi R, Amparore D, Aoun F, Albisinni S, Haroun P, Van Damme J, Peltier A, Bernhard JC, Zlotta AR, Tombal B, Quackels T, Roumeguère T. Mjaess G, et al. Among authors: diamand r. Eur Urol Focus. 2026 Jan 12:S2405-4569(25)00397-9. doi: 10.1016/j.euf.2025.12.017. Online ahead of print. Eur Urol Focus. 2026. PMID: 41530034 Review.
Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004).
Mjaess G, Quackels T, Fantoni JC, Tricard T, Marcq G, Blanc J, Barthelemy P, Carnot A, Sideris S, Awada A, Chanza NM, Peltier A, Albisinni S, Diamand R, Roumeguère T. Mjaess G, et al. Among authors: diamand r. World J Urol. 2026 Jan 13;44(1):90. doi: 10.1007/s00345-026-06192-9. World J Urol. 2026. PMID: 41528535 Clinical Trial.
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder Cancer.
Kwong JCC, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Ringa M, Feifer A, Lajkosz K, Wettstein MS, Chan A, Lee T, Nguyen M, Kassouf W, Black PC, Breau RH, Lodde M, Fairey A, Lattouf JB, Jeldres C, Rendon R, Alimohamed N, Fleshner NE, Diamand R, Gontero P, Sylvester RJ, van Rhijn BWG, Kamat AM, Johnson AEW, Zlotta AR, Kulkarni GS; PROGRxN-BCa Consortium. Kwong JCC, et al. Among authors: diamand r. Eur Urol. 2026 May;89(5):404-413. doi: 10.1016/j.eururo.2025.09.4145. Epub 2025 Oct 7. Eur Urol. 2026. PMID: 41062388
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordant.
Scuderi S; Targeted Biopsies Prostate Cancer Collaborative Group; Tin AL, Marra G, Bianchi L, Kesch C, Soeterik TFW, Ploussard G, Zattoni F, Ettala O, Røder A, Poyet C, Müntener M, Umbehr M, Stroomberg HV, Cimmino U, Fiard G, Nordström T, Patel HD, Gupta GN, Yonover PM, Guillaume B, Gaffney C, Zhuang J, Wang Y, Sarkis J, Jabbour T, Diamand R, Windisch O, Olivier J, Abbadi A, Kim EH, Wang JC, Hu J, Zhu A, Stabile A, Eastham JA, Montorsi F, Briganti A, Gandaglia G; European Association of Urology (EAU) Young Academic Urologists YAU Prostate Cancer Working Party; Vickers AJ. Scuderi S, et al. Among authors: diamand r. J Natl Cancer Inst. 2026 Jan 1;118(1):76-84. doi: 10.1093/jnci/djaf275. J Natl Cancer Inst. 2026. PMID: 41002165
Are Patients with Prostate Imaging Reporting and Data System 5 Lesions Eligible for Active Surveillance? A Multicentric European Study.
Peyrottes A, Baboudjian M, Diamand R, Ducrot Q, Vitard C, Baudewyns A, Windisch O, Anract J, Dariane C, Tricard T, Sarkis J, Sadreux Y, Oderda M, Depaquit TL, La Taille A, Olivier J, Brureau L, Rouviere O, Crouzet S, Ruffion A, Desgrandchamps F, Roumiguie M, Rouprêt M, Ploussard G, Fiard G; CCAFU Group. Peyrottes A, et al. Among authors: diamand r. Eur Urol Oncol. 2025 Oct;8(5):1260-1266. doi: 10.1016/j.euo.2025.01.008. Epub 2025 Feb 17. Eur Urol Oncol. 2025. PMID: 39965998
Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.
Oderda M, Diamand R, Abou Zahr R, Anract J, Assenmacher G, Barry Delongchamps N, Bui AP, Benamran D, Calleris G, Dariane C, Ferriero M, Fiard G, Taha F, Fourcade A, Fournier G, Guenzel K, Halinski A, Marra G, Ploussard G, Rysankova K, Roche JB, Simone G, Windisch O, Gontero P. Oderda M, et al. Among authors: diamand r. World J Urol. 2024 Sep 25;42(1):535. doi: 10.1007/s00345-024-05245-1. World J Urol. 2024. PMID: 39320521 Free PMC article.
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
Mjaess G, Haddad L, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Benijts J, Guenzel K, Roumeguère T, Peltier A, Diamand R. Mjaess G, et al. Among authors: diamand r. Prostate Cancer Prostatic Dis. 2025 Mar;28(1):173-179. doi: 10.1038/s41391-024-00872-6. Epub 2024 Jul 24. Prostate Cancer Prostatic Dis. 2025. PMID: 39048664
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. World J Urol. 2024 Jun 12;42(1):372. doi: 10.1007/s00345-024-05068-0. World J Urol. 2024. PMID: 38866949
Reply to Hein V. Stroomberg, Klaus Brasso, and Andreas Røder's Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Uleri A, Baboudjian M, Diamand R, Ploussard G. Uleri A, et al. Among authors: diamand r. Eur Urol. 2024 Sep;86(3):e66. doi: 10.1016/j.eururo.2024.05.017. Epub 2024 May 24. Eur Urol. 2024. PMID: 38796382 No abstract available.
Reply to Andrew J. Vickers' Letter to the Editor re: Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al. Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment? Eur Urol. In press. https://doi.org/10.1016/j.eururo.2024.02.003.
Uleri A, Baboudjian M, Diamand R, Ploussard G. Uleri A, et al. Among authors: diamand r. Eur Urol. 2024 Sep;86(3):e72. doi: 10.1016/j.eururo.2024.05.016. Epub 2024 May 24. Eur Urol. 2024. PMID: 38796380 No abstract available.
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Baudewyns A, Guenzel K, Halinski A, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Jabbour T, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Zahr RA, Ploussard G, Fiard G, Rysankova K, Bui AP, Taha F, Windisch O, Benamran D, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A, Diamand R. Baudewyns A, et al. Among authors: diamand r. World J Urol. 2024 May 15;42(1):322. doi: 10.1007/s00345-024-04962-x. World J Urol. 2024. PMID: 38747982
Letter to the Editor on "Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System)".
van Velthoven R, Diamand R, Mozer P, Barry de Longchamp N. van Velthoven R, et al. Among authors: diamand r. Urology. 2024 Aug;190:173-174. doi: 10.1016/j.urology.2024.04.050. Epub 2024 May 8. Urology. 2024. PMID: 38729267 No abstract available.
Transrectal prostate biopsy: easy, effective and safe.
Diamand R, Peltier A, Albisinni S. Diamand R, et al. Prostate Cancer Prostatic Dis. 2024 Sep;27(3):363-364. doi: 10.1038/s41391-024-00823-1. Epub 2024 Apr 16. Prostate Cancer Prostatic Dis. 2024. PMID: 38627538 No abstract available.
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Diamand R, Guenzel K, Mjaess G, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Benijts J, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Eur Urol Focus. 2024 Sep;10(5):805-811. doi: 10.1016/j.euf.2024.03.003. Epub 2024 Mar 19. Eur Urol Focus. 2024. PMID: 38508895
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?
Baboudjian M, Diamand R, Uleri A, Beauval JB, Touzani A, Roche JB, Lacetera V, Roumeguère T, Simone G, Benamran D, Fourcade A, Gondran-Tellier B, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: diamand r. Eur Urol. 2024 Sep;86(3):232-237. doi: 10.1016/j.eururo.2024.02.003. Epub 2024 Mar 16. Eur Urol. 2024. PMID: 38494379
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Bourgeno HA, Jabbour T, Baudewyns A, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Vlahopoulos L, Guenzel K, Roumeguère T, Peltier A, Diamand R. Bourgeno HA, et al. Among authors: diamand r. Eur Urol Oncol. 2024 Dec;7(6):1320-1326. doi: 10.1016/j.euo.2024.01.007. Epub 2024 Jan 24. Eur Urol Oncol. 2024. PMID: 38272745
Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair Analysis.
Courboin E, Mathieu R, Panetta V, Mjaess G, Diamand R, Verhoest G, Roumiguié M, Bajeot AS, Soria F, Lonati C, Simeone C, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Mertens LS, Sanchez-Salas R, Colomer A, Cerruto MA, Antonelli A, Krajewski W, Quackels T, Peltier A, Montorsi F, Briganti A, Teoh JYC, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology-Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group. Courboin E, et al. Among authors: diamand r. Cancers (Basel). 2023 Sep 26;15(19):4732. doi: 10.3390/cancers15194732. Cancers (Basel). 2023. PMID: 37835425 Free PMC article.
Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
Mjaess G, Roumeguère T, Diamand R. Mjaess G, et al. Among authors: diamand r. Eur Urol Focus. 2024 Jan;10(1):75-76. doi: 10.1016/j.euf.2023.07.005. Epub 2023 Aug 4. Eur Urol Focus. 2024. PMID: 37543515 No abstract available.
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Baboudjian M, Uleri A, Beauval JB, Touzani A, Diamand R, Roche JB, Lacetera V, Lechevallier E, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: diamand r. Prostate Cancer Prostatic Dis. 2024 Jun;27(2):318-322. doi: 10.1038/s41391-023-00693-z. Epub 2023 Jul 14. Prostate Cancer Prostatic Dis. 2024. PMID: 37452146
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study.
Kwong JCC, Khondker A, Meng E, Taylor N, Kuk C, Perlis N, Kulkarni GS, Hamilton RJ, Fleshner NE, Finelli A, van der Kwast TH, Ali A, Jamal M, Papanikolaou F, Short T, Srigley JR, Colinet V, Peltier A, Diamand R, Lefebvre Y, Mandoorah Q, Sanchez-Salas R, Macek P, Cathelineau X, Eklund M, Johnson AEW, Feifer A, Zlotta AR. Kwong JCC, et al. Among authors: diamand r. Lancet Digit Health. 2023 Jul;5(7):e435-e445. doi: 10.1016/S2589-7500(23)00067-5. Epub 2023 May 19. Lancet Digit Health. 2023. PMID: 37211455 Free article.
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study.
Mjaess G, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S, Diamand R. Mjaess G, et al. Among authors: diamand r. Eur Urol Focus. 2023 Nov;9(6):992-999. doi: 10.1016/j.euf.2023.04.008. Epub 2023 May 3. Eur Urol Focus. 2023. PMID: 37147167
SARS-CoV-2-related bronchiolitis: a multicentre international study.
Cozzi G, Sovtic A, Garelli D, Krivec U, Silvagni D, Corsini I, Colombo M, Giangreco M, Giannattasio A, Milani GP, Minute M, Marchetti F, Gatto A, Debbia C, Gortan AJ, Massaro M, Hatziagorou E, Ravidà D, Diamand R, Jones E, Visekruna J, Zago A, Barbi E, Amaddeo A, Cortellazzo Wiel L; SARS-CoV-2 bronchiolitis study group. Cozzi G, et al. Among authors: diamand r. Arch Dis Child. 2023 Sep;108(9):e15. doi: 10.1136/archdischild-2023-325448. Epub 2023 May 2. Arch Dis Child. 2023. PMID: 37130726 Free article.
Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy.
Fiard G, Seigneurin A, Roumiguié M, Albisinni S, Anract J, Assenmacher G, Barry Delongchamps N, Dariane C, Feyaerts A, Fourcade A, Fournier G, Gontero P, Mastroianni R, Oderda M, Peltier A, Roumeguère T, Saussez T, Simone G, Van Damme J, Descotes JL, Ploussard G, Diamand R. Fiard G, et al. Among authors: diamand r. World J Urol. 2023 May;41(5):1285-1291. doi: 10.1007/s00345-023-04371-6. Epub 2023 Mar 27. World J Urol. 2023. PMID: 36971827
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approach.
Baboudjian M, Breda A, Roumeguère T, Uleri A, Roche JB, Touzani A, Lacetera V, Beauval JB, Diamand R, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, Durand-Labrunie C, Roumiguié M, Sanguedolce F, Oderda M, Barret E, Fromont G, Dariane C, Charvet AL, Gondran-Tellier B, Bastide C, Lechevallier E, Palou J, Ruffion A, Van Der Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: diamand r. World J Urol. 2023 May;41(5):1301-1308. doi: 10.1007/s00345-023-04353-8. Epub 2023 Mar 15. World J Urol. 2023. PMID: 36920491
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum.
Diamand R, D'Hondt F, Mjaess G, Jabbour T, Dell'Oglio P, Larcher A, Moschini M, Quackels T, Peltier A, Assenmacher G, Wiklund P, Breda A, Turri F, De Groote R, Mottrie A, Roumeguere T, Albisinni S; ERUS Educational Working Group, the Junior ERUS/EAU-YAU Robotic Surgery Working Group and the EAU-YAU Urothelial Carcinoma Working Group. Diamand R, et al. BJU Int. 2023 Jul;132(1):84-91. doi: 10.1111/bju.15993. Epub 2023 Mar 26. BJU Int. 2023. PMID: 36815233
Do perioperative blood transfusions impact oncological outcomes of robot-assisted radical cystectomy with intracorporeal urinary diversion? Results from a large multi-institutional registry.
Sarkis J, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Minervini A, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Sarkis J, et al. Among authors: diamand r. Minerva Urol Nephrol. 2023 Feb;75(1):50-58. doi: 10.23736/S2724-6051.22.05109-6. Minerva Urol Nephrol. 2023. PMID: 36800680 Free article.
Magnetic Resonance Imaging-Targeted Biopsy and Pretherapeutic Prostate Cancer Risk Assessment: a Systematic Review: Biopsie ciblée par Imagerie par résonance magnétique et évaluation pré-thérapeutique du risque de cancer de la prostate : revue systématique.
Diamand R, Mjaess G, Ploussard G, Fiard G, Oderda M, Lefebvre Y, Sirtaine N, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Prog Urol. 2022 Jun;32(6S1):6S3-6S18. doi: 10.1016/S1166-7087(22)00170-1. Prog Urol. 2022. PMID: 36719644
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsy.
Diamand R, Peltier A, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Albisinni S. Diamand R, et al. Prostate. 2023 May;83(6):572-579. doi: 10.1002/pros.24490. Epub 2023 Jan 27. Prostate. 2023. PMID: 36705314
Role of the Prostate Imaging Quality PI-QUAL Score for Prostate Magnetic Resonance Image Quality in Pathological Upstaging After Radical Prostatectomy: A Multicentre European Study.
Windisch O, Benamran D, Dariane C, Favre MM, Djouhri M, Chevalier M, Guillaume B, Oderda M, Gatti M, Faletti R, Colinet V, Lefebvre Y, Bodard S, Diamand R, Fiard G. Windisch O, et al. Among authors: diamand r. Eur Urol Open Sci. 2022 Dec 15;47:94-101. doi: 10.1016/j.euros.2022.11.013. eCollection 2023 Jan. Eur Urol Open Sci. 2022. PMID: 36601048 Free PMC article.
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling.
Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, Martin R, Roumeguère T, Peltier A, Diamand R. Noujeim JP, et al. Among authors: diamand r. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):575-580. doi: 10.1038/s41391-022-00620-8. Epub 2022 Dec 12. Prostate Cancer Prostatic Dis. 2023. PMID: 36509930
Reply to Bernardo Rocco and Maria Chiara Sighinolfi's Letter to the Editor re: Romain Diamand, Jean-Baptiste Roche, Elena Lievore, et al. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol Focus 2023;9:309-16.
Diamand R, Albisinni S. Diamand R, et al. Eur Urol Focus. 2023 May;9(3):548. doi: 10.1016/j.euf.2022.10.012. Epub 2022 Nov 10. Eur Urol Focus. 2023. PMID: 36372734 No abstract available.
Oncological outcomes of radical prostatectomy in very high-risk patients according to STAMPEDE criteria: does local treatment alone still have a place in the era of intensified systemic therapies?
Baboudjian M, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Gondran-Tellier B, Roumeguère T, Simone G, Windisch O, Benamran D, Fourcade A, Fiard G, VAN DEN Bergh RC, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: diamand r. Minerva Urol Nephrol. 2023 Feb;75(1):124-126. doi: 10.23736/S2724-6051.22.05121-7. Epub 2022 Oct 25. Minerva Urol Nephrol. 2023. PMID: 36282548 Free article. No abstract available.
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification.
Baboudjian M, Gondran-Tellier B, Touzani A, Martini A, Diamand R, Roche JB, Lacetera V, Beauval JB, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, van den Bergh RCN, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: diamand r. Eur Urol Oncol. 2023 Aug;6(4):406-413. doi: 10.1016/j.euo.2022.09.005. Epub 2022 Oct 21. Eur Urol Oncol. 2023. PMID: 36280445
Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P. Oderda M, et al. Among authors: diamand r. Prostate. 2023 Feb;83(2):162-168. doi: 10.1002/pros.24449. Epub 2022 Oct 19. Prostate. 2023. PMID: 36259316
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?
Diamand R, Albisinni S, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Fourcade A, An Nguyen T, Fournier G, Fiard G, Ploussard G, Peltier A, Roumeguère T. Diamand R, et al. Eur Urol Focus. 2023 Mar;9(2):298-302. doi: 10.1016/j.euf.2022.09.011. Epub 2022 Oct 6. Eur Urol Focus. 2023. PMID: 36210296
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R, Roche JB, Lievore E, Lacetera V, Chiacchio G, Beatrici V, Mastroianni R, Simone G, Windisch O, Benamran D, Favre MM, Fourcade A, Nguyen TA, Fournier G, Fiard G, Ploussard G, Roumeguère T, Peltier A, Albisinni S. Diamand R, et al. Eur Urol Focus. 2023 Mar;9(2):309-316. doi: 10.1016/j.euf.2022.09.006. Epub 2022 Sep 21. Eur Urol Focus. 2023. PMID: 36153227
Antibody-Drug Conjugates in Prostate Cancer: Where Are we?
Mjaess G, Aoun F, Rassy E, Diamand R, Albisinni S, Roumeguère T. Mjaess G, et al. Among authors: diamand r. Clin Genitourin Cancer. 2023 Feb;21(1):171-174. doi: 10.1016/j.clgc.2022.07.009. Epub 2022 Jul 23. Clin Genitourin Cancer. 2023. PMID: 35999150 Review.
Grade group 1 prostate cancer on biopsy: are we still missing aggressive disease in the era of image-directed therapy?
Baboudjian M, Roumiguié M, Peltier A, Oderda M, Barret E, Fromont G, Dariane C, Fiard G, Charvet AL, Gondran-Tellier B, Durand-Labrunie C, Campello PV, Roumeguère T, Diamand R, Diana P, Touzani A, Beauval JB, Daniel L, Rouprêt M, Ruffion A, Ploussard G; French Prostate Cancer Committee of the Association Française d’Urologie (CC-AFU). Baboudjian M, et al. Among authors: diamand r. World J Urol. 2022 Oct;40(10):2423-2429. doi: 10.1007/s00345-022-04130-z. Epub 2022 Aug 18. World J Urol. 2022. PMID: 35980449
Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison.
Mjaess G, Diamand R, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Tay A, Issa R, Roumiguié M, Bajeot AS, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Mertens LS, Sanchez-Salas R, Gallardo AC, Quackels T, Peltier A, Pradere B, Moschini M, Roumeguère T, Albisinni S; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Mjaess G, et al. Among authors: diamand r. Eur J Surg Oncol. 2023 Aug;49(8):1511-1518. doi: 10.1016/j.ejso.2022.07.023. Epub 2022 Aug 11. Eur J Surg Oncol. 2023. PMID: 35970622
Radical Nephroureterectomy Tetrafecta: A Proposal Reporting Surgical Strategy Quality at Surgery.
Soria F, Pradere B, Hurle R, D'Andrea D, Albisinni S, Diamand R, Laukhtina E, Di Trapani E, Aziz A, Krajewski W, Teoh JY, Mari A, Moschini M, Chiancone F, Autorino R, Porreca A, Marchioni M, Liguori G, Lucarelli G, Busetto GM, Foschi N, Antonelli A, Bove P, Russo GI, Crisan N, Borghesi M, Boeri L, Veccia A, Greco F, Longo N, De Cobelli O, Shariat SF, Gontero P, Ferro M; European Association of Urology—Young Academic Urologists EAU-YAU: Urothelial Carcinoma Working Group. Soria F, et al. Among authors: diamand r. Eur Urol Open Sci. 2022 Jun 13;42:1-8. doi: 10.1016/j.euros.2022.05.010. eCollection 2022 Aug. Eur Urol Open Sci. 2022. PMID: 35911084 Free PMC article.
Defining the Morbidity of Robot-Assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Adoption of the Comprehensive Complication Index.
Albisinni S, Diamand R, Mjaess G, Aoun F, Assenmacher G, Assenmacher C, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Minervini A, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sandel N, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Teoh JYC, Pradere B, Moschini M, Roumeguère T. Albisinni S, et al. Among authors: diamand r. J Endourol. 2022 Jun;36(6):785-792. doi: 10.1089/end.2021.0843. Epub 2022 May 17. J Endourol. 2022. PMID: 35109696
Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.
Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P. Artigas C, et al. Among authors: diamand r. Cancers (Basel). 2021 Oct 4;13(19):4982. doi: 10.3390/cancers13194982. Cancers (Basel). 2021. PMID: 34638466 Free PMC article.
Continuing acetylsalicylic acid during Robotic-Assisted Radical Cystectomy with intracorporeal urinary diversion does not increase hemorrhagic complications: results from a large multicentric cohort.
Albisinni S, Diamand R, Mjaess G, Assenmacher G, Assenmacher C, Loos S, Verhoest G, Holz S, Naudin M, Ploussard G, Mari A, Di Maida F, Minervini A, Aoun F, Tay A, Issa R, Roumiguié M, Bajeot AS, Simone G, Anceschi U, Umari P, Sridhar A, Kelly J, Hendricksen K, Einerhand S, Sanchez-Salas R, Colomer A, Quackels T, Peltier A, Montorsi F, Briganti A, Pradere B, Moschini M, Roumeguère T. Albisinni S, et al. Among authors: diamand r. Urol Oncol. 2022 Apr;40(4):163.e11-163.e17. doi: 10.1016/j.urolonc.2021.08.023. Epub 2021 Sep 25. Urol Oncol. 2022. PMID: 34580028
Immune checkpoint inhibitors for BCG-resistant NMIBC: the dawn of a new era.
Albisinni S, Martinez Chanza N, Aoun F, Diamand R, Mjaess G, Azzo JM, Esperto F, Bellmunt J, Roumeguère T, DE Nunzio C. Albisinni S, et al. Among authors: diamand r. Minerva Urol Nephrol. 2021 Jun;73(3):292-298. doi: 10.23736/S2724-6051.21.04309-5. Epub 2021 Mar 29. Minerva Urol Nephrol. 2021. PMID: 33781027 Free article. Review.
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassifications.
Diamand R, Ploussard G, Roumiguié M, Malavaud B, Oderda M, Gontero P, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Peltier A, Simone G, Roche JB, Roumeguère T, Albisinni S. Diamand R, et al. Urol Oncol. 2021 May;39(5):296.e1-296.e9. doi: 10.1016/j.urolonc.2020.08.030. Epub 2020 Oct 9. Urol Oncol. 2021. PMID: 33041188
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Quackels T, Assenmacher G, Simone G, Van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Peltier A, Roumeguère T, Albisinni S. Diamand R, et al. Eur Urol. 2021 Feb;79(2):180-185. doi: 10.1016/j.eururo.2020.09.037. Epub 2020 Oct 3. Eur Urol. 2021. PMID: 33023770
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M, Diamand R, Albisinni S, Calleris G, Carbone A, Falcone M, Fiard G, Gandaglia G, Marquis A, Marra G, Parola C, Pastore A, Peltier A, Ploussard G, Roumeguère T, Sanchez-Salas R, Simone G, Smelzo S, Witt JH, Gontero P. Oderda M, et al. Among authors: diamand r. BJU Int. 2021 Mar;127(3):318-325. doi: 10.1111/bju.15220. Epub 2020 Sep 19. BJU Int. 2021. PMID: 32869940 Free article.
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic.
Diamand R, Ploussard G, Roumiguié M, Oderda M, Benamran D, Fiard G, Peltier A, Simone G, Van Damme J, Malavaud B, Iselin C, Descotes JL, Roche JB, Quackels T, Roumeguère T, Albisinni S. Diamand R, et al. World J Urol. 2021 Jun;39(6):1789-1796. doi: 10.1007/s00345-020-03402-w. Epub 2020 Aug 10. World J Urol. 2021. PMID: 32776243 Free PMC article.
External validation of the Briganti nomogram predicting lymph node invasion in patients with intermediate and high-risk prostate cancer diagnosed with magnetic resonance imaging-targeted and systematic biopsies: A European multicenter study.
Diamand R, Oderda M, Albisinni S, Fourcade A, Fournier G, Benamran D, Iselin C, Fiard G, Descotes JL, Assenmacher G, Svistakov I, Peltier A, Simone G, Di Cosmo G, Roche JB, Bonnal JL, Van Damme J, Rossi M, Mandron E, Gontero P, Roumeguère T. Diamand R, et al. Urol Oncol. 2020 Nov;38(11):847.e9-847.e16. doi: 10.1016/j.urolonc.2020.04.011. Epub 2020 May 26. Urol Oncol. 2020. PMID: 32466877
A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?
Slaoui A, Albisinni S, Aoun F, Assenmacher G, Al Hajj Obeid W, Diamand R, Regragui S, Touzani A, Bakar A, Mesfioui A, Karmouni T, Ameur A, Elkhader K, Koutani A, Ibnattya A, Roumeguere T, Peltier A. Slaoui A, et al. Among authors: diamand r. World J Urol. 2019 Nov;37(11):2343-2353. doi: 10.1007/s00345-019-02652-7. Epub 2019 Jan 31. World J Urol. 2019. PMID: 30706122
Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
Devos B, Al Hajj Obeid W, Andrianne C, Diamand R, Peltier A, Everaerts W, Van Poppel H, Van Velthoven R, Joniau S. Devos B, et al. Among authors: diamand r. World J Urol. 2019 Aug;37(8):1507-1515. doi: 10.1007/s00345-019-02640-x. Epub 2019 Jan 21. World J Urol. 2019. PMID: 30666400
A multicentric study on accurate grading of prostate cancer with systematic and MRI/US fusion targeted biopsies: comparison with final histopathology after radical prostatectomy.
Diamand R, Oderda M, Al Hajj Obeid W, Albisinni S, Van Velthoven R, Fasolis G, Simone G, Ferriero M, Roche JB, Piechaud T, Pastore A, Carbone A, Fiard G, Descotes JL, Marra G, Gontero P, Altobelli E, Papalia R, Kumar P, Eldred-Evans D, Giacobbe A, Muto G, Lacetera V, Beatrici V, Roumeguere T, Peltier A. Diamand R, et al. World J Urol. 2019 Oct;37(10):2109-2117. doi: 10.1007/s00345-019-02634-9. Epub 2019 Jan 16. World J Urol. 2019. PMID: 30652213
Cytoreductive prostatectomy: what is the evidence? A systematic review.
Albisinni S, Aoun F, Diamand R, Al-Hajj Obeid W, Porpiglia F, Roumeguère T, De Nunzio C. Albisinni S, et al. Among authors: diamand r. Minerva Urol Nefrol. 2019 Feb;71(1):1-8. doi: 10.23736/S0393-2249.18.03319-2. Epub 2018 Dec 14. Minerva Urol Nefrol. 2019. PMID: 30547907 Free article.